Develops a platform for biologically designed therapeutics, focusing on AI-enabled methodologies for nucleic manufacture to advance gene-modified cell therapy, gene therapy, and RNA therapeutics. Offers automated solutions for plasmid and library development, as well as industry-leading mRNA development and manufacturing capabilities.